Latest News

• share
• favorite_border

Kimberly Leslie, MD, at The University of New Mexico Comprehensive Cancer Center, leads the UNM portion of the Route 66 Specialized Program of Research Excellence (SPORE) grant. The grant aims to improve uterine cancer survival. The work is a collaboration between scientists at UNM Comprehensive Cancer Center, Siteman Cancer Center at Washington University in St. Louis, and Stephenson Cancer Center at University of Oklahoma. All three universities lie along Route 66, giving the grant its name.

• share
• favorite_border

A research team led by Dr. Hoon Ryu from the Korea Institute of Science and Technology (KIST) has uncovered a new mechanism involving astrocytes for treating Alzheimer’s disease (AD) and proposed a novel therapeutic target.

• share
• favorite_border

A team of researchers from NUS Institute for Health Innovation & Technology (iHealthtech), led by Associate Professor Shao Huilin and Associate Professor Brian Lim, has developed a first-of-its-kind technology to map out diverse protein interactions in cells using DNA barcodes. The technology, dubbed TETRIS, can explicitly identify and quantify multiple interacting partners in large protein assemblies. By capturing the complex hierarchy of protein interactions within tumour cells, the technology uncovers detailed molecular mechanisms driving disease progression. This enables more precise diagnostics, allowing for the accurate sub-typing of cancers and the identification of aggressive forms of the disease in just a few hours, which was not possible previously.

• share
• favorite_border

Analysis of three large, phase III clinical trials finds more than 40% of brain metastases patients completely reversed cognitive losses

• share
• favorite_border

A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with difficult-to-treat meningioma, a type of brain tumor. Findings of the nonrandomized phase II study will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

• share
• favorite_border

In addition to the studies featured on the press program (details here) for the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting, the following studies were recommended by ASTRO experts and may be of interest to journalists.

• share
• favorite_border

Today Kitt Peak Visitor Center celebrated 60 years of greeting visitors to the U.S. National Science Foundation Kitt Peak National Observatory. Since opening in 1964, the Visitor Center has welcomed more than two million guests to the mountain in its mission to inspire a sense of wonder and awe about the Universe through exhibits, daytime tours and nighttime public programs.

• share
• favorite_border

El Centro de Visitas de Kitt Peak celebra 60 años de funcionamiento en el Observatorio Nacional de Kitt Peak de la Fundación Nacional de Ciencias, donde desde su apertura en 1964 ha dado la bienvenida a más de dos millones de personas que han visitado el complejo para conocer su misión de inspirar el asombro y la admiración por el Universo, mediante exposiciones, visitas diurnas y programas públicos nocturnos.

• share
• favorite_border

This special edition features advances in radiation therapy approaches presented by MD Anderson researchers at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting. Information on all MD Anderson ASTRO Annual Meeting content can be found at MDAnderson.org/ASTRO.

• share
• favorite_border

The annual meeting will feature 23 abstracts from UCLA investigators that highlight key areas of radiation oncology, including new research in subspecialties ranging from survivorship, lung cancer/thoracic malignancies, physics, sarcoma, gastrointestinal cancer, genitourinary cancer, gynecological cancer, pediatric cancer and diversity, equity and inclusion in healthcare.

• share
• favorite_border

Leading experts in radiation therapy from Penn Medicine’s Abramson Cancer Center and the Perelman School of Medicine will present new results from clinical trials and research studies at the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting.

• share
• favorite_border

Mercy Medical Center in Baltimore, Maryland, is celebrating, as the nearly 150-year-old hospital recognizes the 30th anniversary of The Weinberg Center for Women’s Health & Medicine.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center today announced its first-ever academic journal, Advances in Cancer Education & Quality Improvement (ACE-QI). The journal will publish research, training program summaries and quality improvement interventions for the oncology provider community.

• share
• favorite_border

• share
• favorite_border

Irvine, Calif., Sept. 27, 2024 — Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body’s internal, 24-hour biological pacemaker, may accelerate the progression of colorectal cancer by affecting the gut microbiome and intestinal barrier function. This discovery offers new avenues for prevention and treatment strategies.

• share
• favorite_border

A new, integrated system will enable ocean science, exploration, and restoration efforts from a wider range of vessels, paving the way for more successful and efficient operations

• share
• favorite_border

Researchers looking for materials that conduct electrons with near-zero resistance at normal operating temperature have found a promising candidate. The material, a layered "sandwich" of bismuth telluride and manganese bismuth telluride structure, exhibits the quantum anomalous Hall effect. In this effect, electrons with their spins all aligned in the same direction can travel along the edges of a material with almost no resistance.

• share
• favorite_border

Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in pharmaceutical industry sponsored clinical trials compared to those conducted with federal government support. Published in The Journal of Clinical Oncology and presented at the ASCO Quality Care Symposium, these findings reveal trends of underinvestment in federally funded studies, flat enrollment counts in federally funded studies over more than a decade and a growing reliance on industry to conduct cancer research.